RPTR-147:2
/ Repertoire
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 06, 2022
KEYNOTE KN-948: RPTR-147 in Patients With Selected Solid Tumors and Lymphomas
(clinicaltrials.gov)
- P1/2 | N=23 | Terminated | Sponsor: Repertoire Immune Medicines | Trial completion date: Jul 2026 ➔ Oct 2022 | Active, not recruiting ➔ Terminated | Trial primary completion date: Jul 2026 ➔ Sep 2022; Development program terminated
Combination therapy • Trial completion date • Trial primary completion date • Trial termination • Head and Neck Cancer • Hematological Malignancies • Lung Cancer • Lymphoma • Melanoma • Non Small Cell Lung Cancer • Oncology • Ovarian Cancer • Solid Tumor • Squamous Cell Carcinoma of Head and Neck
1 to 1
Of
1
Go to page
1